HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael A Nader Selected Research

Dopamine (Intropin)

11/2016Neural Correlates of Exposure to Cocaine Cues in Rhesus Monkeys: Modulation by the Dopamine Transporter.
4/2015Effects of buspirone and the dopamine D3 receptor compound PG619 on cocaine and methamphetamine self-administration in rhesus monkeys using a food-drug choice paradigm.
8/2014Further characterization of quinpirole-elicited yawning as a model of dopamine D3 receptor activation in male and female monkeys.
6/2013Effects of chronic methylphenidate on cocaine self-administration under a progressive-ratio schedule of reinforcement in rhesus monkeys.
2/2013Effects of dopamine D2/D3 receptor ligands on food-cocaine choice in socially housed male cynomolgus monkeys.
11/2012Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates.
9/2012Social dominance in female monkeys: dopamine receptor function and cocaine reinforcement.
1/2012Nonhuman primate models of addiction and PET imaging: dopamine system dysregulation.
9/2010Lower reinforcing strength of the phenyltropane cocaine analogs RTI-336 and RTI-177 compared to cocaine in nonhuman primates.
2/2009Effect of menstrual cycle phase on dopamine D2 receptor availability in female cynomolgus monkeys.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael A Nader Research Topics

Disease

21Cocaine-Related Disorders (Cocaine Addiction)
01/2021 - 11/2002
11Substance-Related Disorders (Drug Abuse)
02/2024 - 11/2004
5Cognitive Dysfunction
01/2021 - 06/2006
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 02/2009
2Parkinson Disease (Parkinson's Disease)
02/2024 - 03/2019
2Alzheimer Disease (Alzheimer's Disease)
02/2024 - 12/2020
2Neuroblastoma
01/2022 - 04/2021
1Major Depressive Disorder (Major Depressive Disorders)
02/2024
1Schizophrenia (Dementia Praecox)
02/2024
1Nervous System Diseases (Neurological Disorders)
02/2024
1Bipolar Disorder (Manic Depressive Psychosis)
02/2024
1Neoplasms (Cancer)
02/2024
1Neurocognitive Disorders (Clerambault Syndrome)
02/2024
1Opioid-Related Disorders (Opiate Addiction)
11/2023
1Neuroinflammatory Diseases
01/2022
1Labyrinthitis (Otitis Interna)
04/2018
1Ataxia (Dyssynergia)
04/2018
1Marijuana Abuse (Cannabis Abuse)
06/2017
1Body Weight (Weight, Body)
04/2016
1Respiratory Insufficiency (Respiratory Failure)
01/2016
1Gambling (Pathological Gambling)
08/2014
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
09/2013
1Sleep Deprivation
09/2013
1Tobacco Use Disorder (Nicotine Dependence)
05/2010
1Hyperthyroidism
03/2008
1Hypothermia
10/2007
1Genetic Predisposition to Disease (Genetic Predisposition)
08/2005

Drug/Important Bio-Agent (IBA)

21Cocaine (Cocaine HCl)IBA
01/2022 - 11/2002
11Dopamine (Intropin)FDA LinkGeneric
11/2016 - 08/2006
5Dopamine D3 ReceptorsIBA
11/2023 - 06/2005
3N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
03/2008 - 10/2007
2Biomarkers (Surrogate Marker)IBA
02/2024 - 11/2016
2Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2021
2Dronabinol (THC)FDA LinkGeneric
01/2018 - 06/2017
2Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2016 - 06/2013
2Methylphenidate (Ritalin)FDA LinkGeneric
09/2013 - 11/2012
2Dextroamphetamine (Dexedrine)FDA LinkGeneric
06/2013 - 05/2010
1Ethanol (Ethyl Alcohol)IBA
04/2021
1Levetiracetam (Keppra)FDA LinkGeneric
01/2021
1MicroRNAs (MicroRNA)IBA
01/2021
1Oxycodone (Oxycontin)FDA LinkGeneric
01/2021
1Cholinergic Agents (Cholinergics)IBA
12/2020
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
12/2020
1phendimetrazine (Bontril)FDA LinkGeneric
01/2020
1VU0652957IBA
03/2019
1Anti-Bacterial Agents (Antibiotics)IBA
04/2018
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
04/2018
1Estradiol (Delestrogen)FDA LinkGeneric
04/2016
12- (N- cyclopropylmethyl- 4,5- epoxy- 6,14- ethano- 3- hydroxy- 6- methoxymorphinan- 7- yl)- 3,3- dimethylpentan- 2- olIBA
01/2016
1Buspirone (Buspar)FDA LinkGeneric
04/2015
1Dopamine Receptors (Dopamine Receptor)IBA
03/2015
1Quetiapine Fumarate (Seroquel)FDA Link
01/2015
1Antipsychotic Agents (Antipsychotics)IBA
01/2015
1Methamphetamine (Desoxyn)FDA LinkGeneric
10/2012
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2012
1Varenicline (Chantix)FDA Link
11/2011
1Dopamine Agonists (Dopamine Agonist)IBA
05/2010
1Opioid Analgesics (Opioids)IBA
05/2010
1NGB 2904IBA
05/2007
1N- (4- (4- (2,3- dichlorophenyl)piperazin- 1- yl)butyl)- 4- (pyridin- 2- yl)benzamideIBA
05/2007
1benzamideIBA
05/2007
1fluoreneIBA
05/2007
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
08/2005
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
07/2004

Therapy/Procedure

6Self Administration (Administration, Self)
09/2014 - 11/2002
3Drug Therapy (Chemotherapy)
01/2021 - 08/2014
2Therapeutics
01/2015 - 07/2004
1Euthanasia (Mercy Killing)
04/2018